Pathogenicity and virulence of human adenovirus F41: Possible links to severe hepatitis in children

References

• Rowe WP, Huebner RJ, Gilmore LK, et al. Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc Soc Exp Biol Med. 1953;84(3):570–21. doi: 10.3181/00379727-84-20714
   PubMed Web of Science ®Google Scholar
• Aoki K, Benkö M, Davison AJ, et al. Toward an integrated human adenovirus designation system that utilizes molecular and serological data and serves both clinical and fundamental virology.J Virol. 2011;85(11):5703–5704. doi: 10.1128/JVI.00491-11
   Google Scholar
• Kajon AE, Echavarria M, de Jong JC. Designation of human adenovirus types based on sequence data: an unfinished debate. J Clin Virol. 2013;58(4):743–744. doi: 10.1016/j.jcv.2013.10.014
   PubMed Web of Science ®Google Scholar
• Seto D, Chodosh J, Brister JR, et al. Using the whole-genome sequence to characterize and name human adenoviruses. J Virol. 2011;85(11):5701–5702. doi: 10.1128/JVI.00354-11
   PubMed Web of Science ®Google Scholar
• Harrach B, Tarján ZL, Benkő M. Adenoviruses across the animal kingdom: a walk in the zoo. FEBS Lett. 2019;593(24):3660–3673. doi: 10.1002/1873-3468.13687
   PubMed Web of Science ®Google Scholar
• Hearing P. Adenoviridae: the viruses and their replication. In: Howley P, D Knipe, J Cohen, and B Damania, editors. Fields Virology: DNA Viruses. Netherlands: Walters Kluwer; 2021. p. 98–128.
   Google Scholar
• Lion T, Wold WSM. Adenoviruses. In: PM H, K DM, C JL, and D BA, editors. Fields Virology: DNA Viruses. Netherlands: Walters Kluwer; 2021. p. 129–171.
   Google Scholar
• Khanal S, Ghimire P, Dhamoon AS. The repertoire of adenovirus in human disease: the innocuous to the deadly. Biomedicines. 2018;6(1):30. doi: 10.3390/biomedicines6010030
   PubMed Web of Science ®Google Scholar
• Lynch JP 3rd, Kajon AE. Adenovirus: epidemiology, global spread of novel serotypes, and advances in treatment and prevention. Semin Respir Crit Care Med. 2016;37(4):586–602. doi: 10.1055/s-0036-1584923
   PubMed Web of Science ®Google Scholar
• Lynch JP 3rd, Kajon AE. Adenovirus: epidemiology, global spread of novel types, and approach to treatment. Semin Respir Crit Care Med. 2021;42(6):800–821. doi: 10.1055/s-0041-1733802
   PubMedGoogle Scholar
• Flewett TH, Morris CA, Bryden AS, et al. Epidemic viral enteritis in a long-stay children’s ward. Lancet. 1975;1(7897):4–5. doi: 10.1016/s0140-6736(75)92370-3
   PubMed Web of Science ®Google Scholar
• Schoub BD, Koornhof HJ, Lecatsas G, et al. Letter: viruses in acute summer gastroenteritis in black infants. Lancet. 1975;1(7915):1093–1094. doi: 10.1016/s0140-6736(75)91869-3
   PubMed Web of Science ®Google Scholar
• de Jong JC, Wigand R, Kidd AH, et al. Candidate adenoviruses 40 and 41: fastidious adenoviruses from human infant stool. J Med Virol. 1983;11(3):215–231. doi: 10.1002/jmv.1890110305
   PubMed Web of Science ®Google Scholar
• Uhnoo I, Wadell G, Svensson L, et al. Two new serotypes of enteric adenovirus causing infantile diarrhoea. Dev Biol Stand. 1983;53:311–318.
   PubMedGoogle Scholar
• Davison AJ, Telford EA, Watson MS, et al. The DNA sequence of adenovirus type 40. J Mol Biol. 1993;234(4):1308–1316. doi: 10.1006/jmbi.1993.1687
   PubMed Web of Science ®Google Scholar
• Mautner V, Steinthorsdottir V, Bailey A. Enteric adenoviruses. Curr Top Microbiol Immunol. 1995;199(Pt 3):229–282. doi: 10.1007/978-3-642-79586-2_12
   PubMed Web of Science ®Google Scholar
• Pérez-Illana M, Martínez M, Condezo GN, et al. Cryo-EM structure of enteric adenovirus HAdV-F41 highlights structural variations among human adenoviruses. Sci Adv. 2021;7(9):eabd9421. 2021 Feb 24. 10.1126/sciadv.abd9421
   PubMed Web of Science ®Google Scholar
• Rafie K, Lenman A, Fuchs J, et al. The structure of enteric human adenovirus 41-A leading cause of diarrhea in children. Sci Adv. 2021;7(2):eabe0974. doi: 10.1126/sciadv.abe0974
   PubMed Web of Science ®Google Scholar
• Albert MJ. Enteric adenoviruses. Brief review. Arch Virol. 1986;88(1–2):1–17. doi: 10.1007/BF01310885
   PubMed Web of Science ®Google Scholar
• Tiemessen CT, Kidd AH. The subgroup F adenoviruses. J Gen Virol. 1995;76(Pt 3):481–497. doi: 10.1099/0022-1317-76-3-481
   PubMedGoogle Scholar
• Uhnoo I, Svensson L, Wadell G. Enteric adenoviruses. Baillieres Clin Gastroenterol. 1990;4(3):627–642. doi: 10.1016/0950-3528(90)90053-j
   PubMedGoogle Scholar
• Wadell G, Allard A, Johannson M, et al. Enteric adenoviruses. In: Kapikian A, editor. Viral infections of the gastrointestinal tract. New York: Marcel Dekker; 1994. p. 57–74.
   Google Scholar
• Wadell G, Allard A, Johansson M, et al. Enteric adenoviruses. Ciba Found Symp. 1987;128:63–91. doi: 10.1002/9780470513460.ch5
   PubMedGoogle Scholar
• Whitelaw A, Davies H, Parry J. Electron microscopy of fatal adenovirus gastroenteritis. Lancet. 1977;1(8007):361. doi: 10.1016/s0140-6736(77)91158-8
   PubMed Web of Science ®Google Scholar
• de Souza EV, de Souza YFVP, Medeiros RS, et al. Diversity of enteric and non-enteric human adenovirus strains in Brazil, 2006-2011. Arch Virol. 2021;166(3):897–903. doi: 10.1007/s00705-020-04946-3
   PubMed Web of Science ®Google Scholar
• Hierholzer JC. Adenoviruses in the immunocompromised host. Clin Microbiol Rev. 1992;5(3):262–274. doi: 10.1128/CMR.5.3.262
   PubMed Web of Science ®Google Scholar
• Thea DM, Glass R, Grohmann GS, et al. Prevalence of enteric viruses among hospital patients with AIDS in Kinshasa, Zaire. Trans R Soc Trop Med Hyg. 1993b;87(3):263–266. doi: 10.1016/0035-9203(93)90119-b PMID: 8236386.
   PubMed Web of Science ®Google Scholar
• Thea DM, St Louis ME, Atido U, et al. A prospective study of diarrhea and HIV-1 infection among 429 Zairian infants. N Engl J Med. 1993a;329(23):1696–1702. doi: 10.1056/NEJM199312023292304
   PubMed Web of Science ®Google Scholar
• Kroes AC, de Klerk EP, Lankester AC, et al. Sequential emergence of multiple adenovirus serotypes after pediatric stem cell transplantation.J Clin Virol. J Clin Virol. 2007;38(4):341–347. doi: 10.1016/j.jcv.2007.01.001
   PubMed Web of Science ®Google Scholar
• Lion T, Kosulin K, Landlinger C, et al. Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation. Leukemia. 2010;24(4):706–714. doi: 10.1038/leu.2010.4
   PubMed Web of Science ®Google Scholar
• Lion T. Adenovirus infections in immunocompetent and immunocompromised patients. Clin Microbiol Rev. 2014;27(3):441–462. doi: 10.1128/CMR.00116-13
   PubMed Web of Science ®Google Scholar
• Kosulin K. Intestinal HAdV infection: tissue specificity, persistence, and implications for antiviral therapy. Viruses. 2019;11(9):804. doi: 10.3390/v11090804
   PubMed Web of Science ®Google Scholar
• Green M, Wold WS, Mackey JK, et al. Analysis of human tonsil and cancer DNAs and RNAs for DNA sequences of group C (serotypes 1, 2, 5, and 6) human adenoviruses. Proc Natl Acad Sci U S A. 1979;76(12):6606–6610. doi: 10.1073/pnas.76.12.6606
   PubMed Web of Science ®Google Scholar
• Hogg JC. Role of latent viral infections in chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med. 2001;164(10 Pt 2):S71–5. doi: 10.1164/ajrccm.164.supplement_2.2106063
   PubMed Web of Science ®Google Scholar
• Kosulin K, Geiger E, Vécsei A, et al. Persistence and reactivation of human adenoviruses in the gastrointestinal tract. Clin Microbiol Infect. 2016;22(4):.e381.1–.e381.8. doi: 10.1016/j.cmi.2015.12.013
   Web of Science ®Google Scholar
• Leung AY, Chan M, Cheng VC, et al. Quantification of adenovirus in the lower respiratory tract of patients without clinical adenovirus-related respiratory disease. Clin Infect Dis. 2005;40(10):1541–1544. doi: 10.1086/429627
   PubMed Web of Science ®Google Scholar
• Roy S, Calcedo R, Medina-Jaszek A, et al. Adenoviruses in lymphocytes of the human gastro-intestinal tract. PLoS One. 2011;6(9):e24859. doi: 10.1371/journal.pone.0024859
   PubMed Web of Science ®Google Scholar
• Fox JP, Brandt CD, Wassermann FE, et al. The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. VI. Observations of adenovirus infections: virus excretion patterns, antibody response, efficiency of surveillance, patterns of infections, and relation to illness. Am J Epidemiol. 1969 Jan;89(1):25–50.
   PubMed Web of Science ®Google Scholar
• Fox JP, Hall CE, Cooney MK. The Seattle virus watch. VII. Observations of adenovirus infections. Am J Epidemiol. 1977;105(4):362–386. doi: 10.1093/oxfordjournals.aje.a112394
   PubMed Web of Science ®Google Scholar
• Garnett CT, Erdman D, Xu W, et al. Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes. J Virol. 2002;76(21):10608–10616. doi: 10.1128/jvi.76.21.10608-10616.2002
   PubMed Web of Science ®Google Scholar
• Garnett CT, Talekar G, Mahr JA, et al. Latent species C adenoviruses in human tonsil tissues. J Virol. 2009;83(6):2417–2428. doi: 10.1128/JVI.02392-08
   PubMed Web of Science ®Google Scholar
• Neumann R, Genersch E, Eggers HJ. Detection of adenovirus nucleic acid sequences in human tonsils in the absence of infectious virus. Virus Res. 1987;7(1):93–97. doi: 10.1016/0168-1702(87)90060-8
   PubMed Web of Science ®Google Scholar
• Lion T. Adenovirus persistence, reactivation, and clinical management. FEBS Lett. 2019;593(24):3571–3582. doi: 10.1002/1873-3468.13576
   PubMed Web of Science ®Google Scholar
• Hoffman JA. Adenovirus infections in solid organ transplant recipients. Curr Opin Organ Transplant. 2009;14(6):625–633. doi: 10.1097/MOT.0b013e3283324e1b
   PubMed Web of Science ®Google Scholar
• Lion T, Baumgartinger R, Watzinger F, et al. Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood. 2003;102(3):1114–1120. doi: 10.1182/blood-2002-07-2152
   PubMed Web of Science ®Google Scholar
• Zheng Y, Stamminger T, Hearing P. E2F/Rb family proteins mediate interferon induced repression of adenovirus immediate early transcription to promote persistent viral infection. PLOS Pathog. 2016;12(1):e1005415. doi: 10.1371/journal.ppat.1005415
   PubMed Web of Science ®Google Scholar
• Prasad V, Suomalainen M, Jasiqi Y, et al. The UPR sensor IRE1α and the adenovirus E3-19K glycoprotein sustain persistent and lytic infections. Nat Commun. 2020;11(1):1997. doi: 10.1038/s41467-020-15844-2
   PubMed Web of Science ®Google Scholar
• Bergelson JM, Cunningham JA, Droguett G, et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science. 1997;275(5304):1320–1323. doi: 10.1126/science.275.5304.1320
   PubMed Web of Science ®Google Scholar
• Roelvink PW, Lizonova A, Lee JG, et al. The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J Virol. 1998;72(10):7909–7915. doi: 10.1128/JVI.72.10.7909-7915.1998
   PubMed Web of Science ®Google Scholar
• Gaggar A, Shayakhmetov DM, Lieber A. CD46 is a cellular receptor for group B adenoviruses.Nat med. 2003;9(11):1408–1412.doi: 10.1038/nm952
   Google Scholar
• Stasiak AC, Stehle T. Human adenovirus binding to host cell receptors: a structural view. Med Microbiol Immunol. 2020;209(3):325–333. doi: 10.1007/s00430-019-00645-2
   PubMed Web of Science ®Google Scholar
• Yeh HY, Pieniazek N, Pieniazek D, et al. Genetic organization, size, and complete sequence of early region 3 genes of human adenovirus type 41. J Virol. 1996;70(4):2658–2663. doi: 10.1128/jvi.70.4.2658-2663.1996
   PubMed Web of Science ®Google Scholar
• Kidd AH, Chroboczek J, Cusack S, et al. Adenovirus type 40 virions contain two distinct fibers. Virology. 1993;192(1):73–84. doi: 10.1006/viro.1993.1009
   PubMed Web of Science ®Google Scholar
• Rajan A, Palm E, Trulsson F, et al. Heparan sulfate is a cellular receptor for enteric human adenoviruses. Viruses. 2021;13(2):298. doi: 10.3390/v13020298
   PubMed Web of Science ®Google Scholar
• Rajan A, Persson BD, Frängsmyr L, et al. Enteric species F human adenoviruses use laminin-binding integrins as co-receptors for infection of Ht-29 cells. Sci Rep. 2018;8(1):10019. doi: 10.1038/s41598-018-28255-7
   PubMedGoogle Scholar
• Albinsson B, Kidd AH. Adenovirus type 41 lacks an RGD alpha(v)-integrin binding motif on the penton base and undergoes delayed uptake in A549 cells. Virus Res. 1999;64(2):125–136. doi: 10.1016/s0168-1702(99)00087-8
   PubMed Web of Science ®Google Scholar
• Favier AL, Burmeister WP, Chroboczek J. Unique physicochemical properties of human enteric Ad41 responsible for its survival and replication in the gastrointestinal tract. Virology. 2004;322(1):93–104. doi: 10.1016/j.virol.2004.01.020
   PubMed Web of Science ®Google Scholar
• Stewart RL, O’Connor KL. Clinical significance of the integrin α6β4 in human malignancies. Lab Invest. 2015;95(9):976–986. doi: 10.1038/labinvest.2015.82
   PubMed Web of Science ®Google Scholar
• Williams JM, Duckworth CA, Burkitt MD, et al. Epithelial cell shedding and barrier function: a matter of life and death at the small intestinal villus tip. Vet Pathol. 2015;52(3):445–455. doi: 10.1177/0300985814559404
   PubMed Web of Science ®Google Scholar
• Arnberg N. Adenovirus receptors: implications for targeting of viral vectors. Trends Pharmacol Sci. 2012;33(8):442–448. doi: 10.1016/j.tips.2012.04.005
   PubMed Web of Science ®Google Scholar
• Khare R, Reddy VS, Nemerow GR, et al. Identification of adenovirus serotype 5 hexon regions that interact with scavenger receptors.J Virol. 2012;86(4):2293–2301.doi: 10.1128/JVI.05760-11
   Google Scholar
• Maler MD, Nielsen PJ, Stichling N, et al. Key role of the scavenger receptor MARCO in mediating adenovirus infection and subsequent innate responses of macrophages. MBio. 2017;8(4):e00670–17. doi: 10.1128/mBio.00670-17
   PubMed Web of Science ®Google Scholar
• Stichling N, Suomalainen M, Flatt JW, et al. Lung macrophage scavenger receptor SR-A6 (MARCO) is an adenovirus type-specific virus entry receptor. PLOS Pathog. 2018;14(3):e1006914. doi: 10.1371/journal.ppat.1006914
   PubMed Web of Science ®Google Scholar
• Greber UF, Flatt JW. Adenovirus entry: from infection to immunity. Annu Rev Virol. 2019;6(1):177–197. doi: 10.1146/annurev-virology-092818-015550
   PubMedGoogle Scholar
• Greber UF, Singh I, Helenius A. Mechanisms of viral un coating. Trends Microbiol. 1994;2(2):52–56. doi: 10.1016/0966-842x(94)90126-0
   PubMedGoogle Scholar
• Greber UF, Suomalainen M. Adenovirus entry: stability, uncoating, and nuclear import. Mol Microbiol. 2022;118(4):309–320. doi: 10.1111/mmi.14909
   PubMed Web of Science ®Google Scholar
• Greber UF, Willetts M, Webster P, et al. Stepwise dismantling of adenovirus 2 during entry into cells. Cell. 1993;75(3):477–486. doi: 10.1016/0092-8674(93)90382-z
   PubMed Web of Science ®Google Scholar
• Nakano MY, Boucke K, Suomalainen M, et al. The first step of adenovirus type 2 disassembly occurs at the cell surface, independently of endocytosis and escape to the cytosol. J Virol. 2000;74(15):7085–7095. doi: 10.1128/jvi.74.15.7085-7095.2000
   PubMed Web of Science ®Google Scholar
• Puntener D, Engelke MF, Ruzsics Z, et al. Stepwise loss of fluorescent core protein V from human adenovirus during entry into cells. J Virol. 2011;85(1):481–496. doi: 10.1128/JVI.01571-10
   PubMed Web of Science ®Google Scholar
• Bremner KH, Scherer J, Yi J, et al. Adenovirus transport via direct interaction of cytoplasmic dynein with the viral capsid hexon subunit. Cell Host Microbe. 2009;6(6):523–535. doi: 10.1016/j.chom.2009.11.006
   PubMed Web of Science ®Google Scholar
• Dales S, Chardonnet Y. Early events in the interaction of adenoviruses with HeLa cells. IV. Association with microtubules and the nuclear pore complex during vectorial movement of the inoculum. Virology. 1973;56(2):465–483. doi: 10.1016/0042-6822(73)90050-0
   PubMed Web of Science ®Google Scholar
• Miles BD, Luftig RB, Weatherbee JA, et al. Quantitation of the interaction between adenovirus types 2 and 5 and microtubules inside infected cells. Virology. 1980;105(1):265–269. doi: 10.1016/0042-6822(80)90177-4
   PubMed Web of Science ®Google Scholar
• Wang IH, Burckhardt CJ, Yakimovich A, et al. Imaging, tracking and computational analyses of virus entry and egress with the cytoskeleton. Viruses. 2018;10(4):166. doi: 10.3390/v10040166
   PubMed Web of Science ®Google Scholar
• Scherer J, Vallee RB. Adenovirus recruits dynein by an evolutionary novel mechanism involving direct binding to Ph-primed hexon. Viruses. 2011;3(8):1417–1431. doi: 10.3390/v3081417
   PubMed Web of Science ®Google Scholar
• Zhou J, Scherer J, Yi J, et al. Role of kinesins in directed adenovirus transport and cytoplasmic exploration. PLOS Pathog. 2018;14(5):e1007055. doi: 10.1371/journal.ppat.1007055
   PubMed Web of Science ®Google Scholar
• Scherer J, Yi J, Vallee RB. Role of cytoplasmic dynein and kinesins in adenovirus transport. FEBS Lett. 2020;594(12):1838–1847. doi: 10.1002/1873-3468.13777
   PubMed Web of Science ®Google Scholar
• Cassany A, Ragues J, Guan T, et al. Nuclear import of adenovirus DNA involves direct interaction of hexon with an N-terminal domain of the nucleoporin Nup214. J Virol. 2015;89(3):1719–1730. doi: 10.1128/JVI.02639-14
   PubMed Web of Science ®Google Scholar
• Trotman LC, Mosberger N, Fornerod M, et al. Import of adenovirus DNA involves the nuclear pore complex receptor CAN/Nup214 and histone H1. Nat Cell Biol. 2001;3(12):1092–1100. doi: 10.1038/ncb1201-1092
   PubMed Web of Science ®Google Scholar
• Wang IH, Burckhardt CJ, Yakimovich A, et al. The nuclear export factor CRM1 controls juxta-nuclear microtubule-dependent virus transport. J Cell Sci. 2017;130(13):2185–2195. doi: 10.1242/jcs.203794
   PubMed Web of Science ®Google Scholar
• Bauer M, Flatt JW, Seiler D, et al. The E3 ubiquitin ligase mind bomb 1 controls adenovirus genome release at the nuclear pore complex. Cell Rep. 2019;29(12):3785–3795.e8. doi: 10.1016/j.celrep.2019.11.064
   PubMed Web of Science ®Google Scholar
• Sarbanes SL, Blomen VA, Lam E, et al. E3 ubiquitin ligase mindbomb 1 facilitates nuclear delivery of adenovirus genomes. Proc Natl Acad Sci U S A. 2021;118(1):e2015794118. doi: 10.1073/pnas.2015794118
   PubMed Web of Science ®Google Scholar
• Shayakhmetov DM, Li ZY, Ternovoi V, et al. The interaction between the fiber knob domain and the cellular attachment receptor determines the intracellular trafficking route of adenoviruses. J Virol. 2003;77(6):3712–3723. doi: 10.1128/jvi.77.6.3712-3723.2003
   PubMed Web of Science ®Google Scholar
• Witt DJ, Bousquet EB. Comparison of enteric adenovirus infection in various human cell lines. J Virol Methods. 1988;20(4):295–308. doi: 10.1016/0166-0934(88)90133-4
   PubMed Web of Science ®Google Scholar
• Brown M, Wilson-Friesen HL, Doane F. A block in release of progeny virus and a high particle-to-infectious unit ratio contribute to poor growth of enteric adenovirus types 40 and 41 in cell culture. J Virol. 1992;66(5):3198–3205. doi: 10.1128/JVI.66.5.3198-3205.1992
   PubMed Web of Science ®Google Scholar
• Lemiale F, Haddada H, Nabel GJ, et al. Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41. Vaccine. 2007;25(11):2074–2084. doi: 10.1016/j.vaccine.2006.11.025
   PubMed Web of Science ®Google Scholar
• Yamasaki S, Miura Y, Brown E, et al. Development of a method for effective amplification of human adenovirus 40. Arch Virol. 2010;155(7):1059–1068. doi: 10.1007/s00705-010-0683-3
   PubMed Web of Science ®Google Scholar
• Blackford AN, Grand RJ. Adenovirus E1B 55-kilodalton protein: multiple roles in viral infection and cell transformation. J Virol. 2009;83(9):4000–4012. doi: 10.1128/JVI.02417-08
   PubMed Web of Science ®Google Scholar
• Götting J, Cordes AK, Steinbrück L, et al. Molecular phylogeny of human adenovirus type 41 lineages. eCollection 2022 Virus Evol. 2022;8(2):veac098. doi: 10.1093/ve/veac098
   PubMed Web of Science ®Google Scholar
• Ebner K, Pinsker W, Lion T. Comparative sequence analysis of the hexon gene in the entire spectrum of human adenovirus serotypes: phylogenetic, taxonomic, and clinical implications. J Virol. 2005;79(20):12635–12642. doi: 10.1128/JVI.79.20.12635-12642.2005
   PubMed Web of Science ®Google Scholar
• Gilson T, Blanchette P, Ballmann MZ, et al. Using the E4orf6-based E3 ubiquitin ligase as a tool to analyze the evolution of adenoviruses. J Virol. 2016;90(16):7350–7367. doi: 10.1128/JVI.00420-16
   PubMed Web of Science ®Google Scholar
• Madisch I, Harste G, Pommer H, et al. Phylogenetic analysis of the main neutralization and hemagglutination determinants of all human adenovirus prototypes as a basis for molecular classification and taxonomy.J. Virol. 2005;79(24):15265–15276. doi: 10.1128/JVI.79.24.15265-15276.2005
   Web of Science ®Google Scholar
• Madisch I, Hofmayer S, Moritz C, et al. Phylogenetic analysis and structural predictions of human adenovirus penton proteins as a basis for tissue-specific adenovirus vector design. J Virol. 2007;81(15):8270–8281. doi: 10.1128/JVI.00048-07
   PubMed Web of Science ®Google Scholar
• Madisch I, Wölfel R, Harste G, et al. Molecular identification of adenovirus sequences: a rapid scheme for early typing of human adenoviruses in diagnostic samples of immunocompetent and immunodeficient patients. J Med Virol. 2006;78(9):1210–1217. doi: 10.1002/jmv.20683
   PubMed Web of Science ®Google Scholar
• Avvakumov N, Kajon AE, Hoeben RC, et al. Comprehensive sequence analysis of the E1A proteins of human and simian adenoviruses. Virology. 2004;329(2):477–492. doi: 10.1016/j.virol.2004.08.007
   PubMed Web of Science ®Google Scholar
• van Loon AE, Ligtenberg M, Reemst AM, et al. Structure and organization of the left-terminal DNA regions of fastidious adenovirus types 40 and 41. Gene. 1987;58(1):109–126. doi: 10.1016/0378-1119(87)90034-5
   PubMed Web of Science ®Google Scholar
• Cheng CY, Gilson T, Dallaire F, et al. The E4orf6/E1B55K E3 ubiquitin ligase complexes of human adenoviruses exhibit heterogeneity in composition and substrate specificity. J Virol. 2011;85(2):765–775. doi: 10.1128/JVI.01890-10
   PubMed Web of Science ®Google Scholar
• Cheng CY, Gilson T, Wimmer P, et al. Role of E1B55K in E4orf6/E1B55K E3 ligase complexes formed by different human adenovirus serotypes. J Virol. 2013;87(11):6232–6245. doi: 10.1128/JVI.00384-13
   PubMed Web of Science ®Google Scholar
• Cousin C, Winter N, Gomes SA, et al. Cellular transformation by E1 genes of enteric adenoviruses. Virology. 1991;181(1):277–287. doi: 10.1016/0042-6822(91)90493-u
   PubMed Web of Science ®Google Scholar
• Bailey A, Mautner V. Phylogenetic relationships among adenovirus serotypes. Virology. 1994;205(2):438–452. doi: 10.1006/viro.1994.1664
   PubMed Web of Science ®Google Scholar
• Lichtenstein DL, Toth K, Doronin K, et al. Functions and mechanisms of action of the adenovirus E3 proteins. Int Rev Immunol. 2004;23(1–2):75–111. doi: 10.1080/08830180490265556
   PubMed Web of Science ®Google Scholar
• Frietze KM, Campos SK, Kajon AE. No evidence of a death-like function for species B1 human adenovirus type 3 E3-9K during A549 cell line infection. BMC Res Notes. 2012;5(1):429. doi: 10.1186/1756-0500-5-429
   PubMedGoogle Scholar
• Lu ZZ, Zou XH, Lastinger K, et al. Enhanced growth of recombinant human adenovirus type 41 (HAdV-41) carrying ADP gene. Virus Res. 2013;176(1–2):61–68. doi: 10.1016/j.virusres.2013.05.003
   PubMed Web of Science ®Google Scholar
• Mautner V, Mackay N. Enteric adenovirus type 40: complementation of the E4 defect in Ad2 dl808. Virology. 1991;183(1):433–436. doi: 10.1016/0042-6822(91)90161-4
   PubMed Web of Science ®Google Scholar
• Querido E, Blanchette P, Yan Q, et al. Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex. Genes Dev. 2001;15(23):3104–3117. doi: 10.1101/gad.926401
   PubMed Web of Science ®Google Scholar
• Schreiner S, Wimmer P, Dobner T. Adenovirus degradation of cellular proteins. Future Microbiol. 2012;7(2):211–225. doi: 10.2217/fmb.11.153
   PubMed Web of Science ®Google Scholar
• Blackford AN, Patel RN, Forrester NA, et al. Adenovirus 12 E4orf6 inhibits ATR activation by promoting TOPBP1 degradation. Proc Natl Acad Sci U S A. 2010;107(27):12251–12256. doi: 10.1073/pnas.0914605107
   PubMed Web of Science ®Google Scholar
• Gilson T, Cheng CY, Hur WS, et al. Analysis of the Cullin binding sites of the E4orf6 proteins of human adenovirus E3 ubiquitin ligases. J Virol. 2014;88(7):3885–3897. doi: 10.1128/JVI.03579-13
   PubMed Web of Science ®Google Scholar
• Cheng L, Huang X, Li X, et al. Cryo-EM structures of two bovine adenovirus type 3 intermediates. Virology. 2014;450-451:174–181. doi: 10.1016/j.virol.2013.12.012
   PubMed Web of Science ®Google Scholar
• Kundhavai Natchiar S, Venkataraman S, Mullen TM, et al. Revised crystal structure of human adenovirus reveals the limits on protein IX quasi-equivalence and on analyzing large macromolecular complexes. J Mol Biol. 2018;430(21):4132–4141. doi: 10.1016/j.jmb.2018.08.011
   PubMed Web of Science ®Google Scholar
• Liu H, Jin L, Koh SB, et al. Atomic structure of human adenovirus by cryo-EM reveals interactions among protein networks. Science. 2010;329(5995):1038–1043. doi: 10.1126/science.1187433
   PubMed Web of Science ®Google Scholar
• Marabini R, Condezo GN, Krupovic M, et al. Near-atomic structure of an atadenovirus reveals a conserved capsid-binding motif and intergenera variations in cementing proteins. Sci Adv. 2021;7(14):eabe6008. doi: 10.1126/sciadv.abe6008
   PubMed Web of Science ®Google Scholar
• Menéndez-Conejero R, Nguyen TH, Singh AK, et al. Structure of a reptilian adenovirus reveals a phage tailspike fold stabilizing a vertebrate virus capsid. Structure. 2017;25(10):1562–1573.e5. doi: 10.1016/j.str.2017.08.007
   PubMed Web of Science ®Google Scholar
• Reddy VS, Natchiar SK, Stewart PL, et al. Crystal structure of human adenovirus at 3.5 a resolution. Science. 2010;329(5995):1071–1075. doi: 10.1126/science.1187292
   PubMed Web of Science ®Google Scholar
• Yu X, Veesler D, Campbell MG, et al. Cryo-EM structure of human adenovirus D26 reveals the conservation of structural organization among human adenoviruses. Sci Adv. 2017;3(5):e1602670. doi: 10.1126/sciadv.1602670
   PubMed Web of Science ®Google Scholar
• Toogood CI, Hay RT. DNA sequence of the adenovirus type 41 hexon gene and predicted structure of the protein. J Gen Virol. 1988;69(Pt 9):2291–2301. doi: 10.1099/0022-1317-69-9-2291
   PubMedGoogle Scholar
• Toogood CI, Murali R, Burnett RM, et al. The adenovirus type 40 hexon: sequence, predicted structure and relationship to other adenovirus hexons. J Gen Virol. 1989;70(Pt 12):3203–3214. doi: 10.1099/0022-1317-70-12-3203
   PubMedGoogle Scholar
• Yu X, Mullen TM, Abrishami V, et al. Structure of a cell entry defective human adenovirus provides insights into precursor proteins and capsid maturation. J Mol Biol. 2022;434(2):167350. doi: 10.1016/j.jmb.2021.167350
   PubMed Web of Science ®Google Scholar
• Pieniazek NJ, Slemenda SB, Pieniazek D, et al. Human enteric adenovirus type 41 (Tak) contains a second fiber protein gene. Nucleic Acids Res. 1990;18(7):1901. doi: 10.1093/nar/18.7.1901
   PubMed Web of Science ®Google Scholar
• Yeh HY, Pieniazek N, Pieniazek D, et al. Human adenovirus type 41 contains two fibers. Virus Res. 1994;33(2):179–198. doi: 10.1016/0168-1702(94)90054-x
   PubMed Web of Science ®Google Scholar
• Seiradake E, Cusack S. Crystal structure of enteric adenovirus serotype 41 short fiber head. J Virol. 2005;79(22):14088–14094. doi: 10.1128/JVI.79.22.14088-14094.2005
   PubMed Web of Science ®Google Scholar
• Gallardo J, Pérez-Illana M, Martín-González N, et al. Adenovirus structure: what is new? Int J Mol Sci. 2021;22(10):5240. doi: 10.3390/ijms22105240
   PubMed Web of Science ®Google Scholar
• Dai X, Wu L, Sun R, et al. Atomic structures of minor proteins VI and VII in human adenovirus. J Virol. 2017;91(24):e00850–17. doi: 10.1128/JVI.00850-17
   PubMed Web of Science ®Google Scholar
• Nemerow GR, Stewart PL. Insights into adenovirus uncoating from interactions with integrins and mediators of host immunity. Viruses. 2016;8(12):337. doi: 10.3390/v8120337
   PubMed Web of Science ®Google Scholar
• Nguyen EK, Nemerow GR, Smith JG. Direct evidence from single-cell analysis that human {alpha}-defensins block adenovirus uncoating to neutralize infection. J Virol. 2010;84(8):4041–4049. doi: 10.1128/JVI.02471-09
   PubMed Web of Science ®Google Scholar
• Smith JG, Nemerow GR. Mechanism of adenovirus neutralization by human alpha-defensins. Cell Host Microbe. 2008;3(1):11–19. doi: 10.1016/j.chom.2007.12.001
   PubMed Web of Science ®Google Scholar
• Smith JG, Silvestry M, Lindert S, et al. Insight into the mechanisms of adenovirus capsid disassembly from studies of defensin neutralization. PLOS Pathog. 2010;6(6):e1000959. doi: 10.1371/journal.ppat.1000959
   PubMed Web of Science ®Google Scholar
• Flatt JW, Kim R, Smith JG, et al. An intrinsically disordered region of the adenovirus capsid is implicated in neutralization by human alpha defensin 5. PLoS One. 2013;8(4):e61571. Print 2013. doi: 10.1371/journal.pone.0061571
   PubMed Web of Science ®Google Scholar
• Beatty MS, Curiel DT. Chapter two–adenovirus strategies for tissue-specific targeting. Adv Cancer Res. 2012;115:39–67. doi: 10.1016/B978-0-12-398342-8.00002-1
   PubMed Web of Science ®Google Scholar
• Watanabe M, Nishikawaji Y, Kawakami H, et al. Adenovirus biology, recombinant adenovirus, and adenovirus usage in gene therapy. Viruses. 2021;13(12):2502. doi: 10.3390/v13122502
   PubMed Web of Science ®Google Scholar
• Wold WS, Toth K. Adenovirus vectors for gene therapy, vaccination and cancer gene therapy. Curr Gene Ther. 2013;13(6):421–433. doi: 10.2174/1566523213666131125095046
   PubMed Web of Science ®Google Scholar
• Buckinx R, Timmermans JP. Targeting the gastrointestinal tract with viral vectors: state of the art and possible applications in research and therapy. Histochem Cell Biol. 2016;146(6):709–720. doi: 10.1007/s00418-016-1496-6
   PubMed Web of Science ®Google Scholar
• Croyle MA, Stone M, Amidon GL, et al. In vitro and in vivo assessment of adenovirus 41 as a vector for gene delivery to the intestine. Gene Ther. 1998;5(5):645–654. doi: 10.1038/sj.gt.3300645
   PubMed Web of Science ®Google Scholar
• Grand RJ. A link between severe hepatitis in children and adenovirus 41 and adeno-associated virus 2 infections. J Gen Virol. 2022;103(11). doi: 10.1099/jgv.0.001783
   PubMed Web of Science ®Google Scholar
• Ilic I, Ilic M. Multi-country outbreak of severe acute hepatitis of unknown origin in children, 2022. Acta Paediatr. 2023;112(6):1148–1156. doi: 10.1111/apa.16685
   PubMed Web of Science ®Google Scholar
• Karpen SJ. Acute hepatitis in children in 2022 - human adenovirus 41? N Engl J Med. 2022;387(7):656–657. doi: 10.1056/NEJMe2208409
   PubMed Web of Science ®Google Scholar
• Matthews PC, Campbell C, Săndulescu O, et al. Acute severe hepatitis outbreak in children: A perfect storm. What do we know, and what questions remain? Front Pharmacol. 2022;13:1062408. doi: 10.3389/fphar.2022.1062408
   PubMed Web of Science ®Google Scholar
• Uwishema O, Mahmoud A, Wellington J, et al. A review on acute, severe hepatitis of unknown origin in children: A call for concern. Ann Med Surg (Lond). 2022;81:104457. doi: 10.1016/j.amsu.2022.104457
   PubMed Web of Science ®Google Scholar
• Wang C, Gao ZY, Walsh N, et al. Acute hepatitis of unknown aetiology among children around the world. Infect Dis Poverty. 2022;11(1):112. doi: 10.1186/s40249-022-01035-2
   PubMed Web of Science ®Google Scholar
• Bucuvalas J, Yazigi N, RH S Jr. Acute liver failure in children. vii Clin Liver Dis. 2006;10(1):149–168. doi: 10.1016/j.cld.2005.10.006
   PubMedGoogle Scholar
• Squires RH Jr, Shneider BL, Bucuvalas J, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006;148(5):652–658. doi: 10.1016/j.jpeds.2005.12.051
   PubMed Web of Science ®Google Scholar
• Kelgeri C, Couper M, Gupte GL, et al. Clinical spectrum of children with acute hepatitis of unknown cause. N Engl J Med. 2022;387(7):611–619. doi: 10.1056/NEJMoa2206704
   PubMed Web of Science ®Google Scholar
• Gutierrez Sanchez LH, Shiau H, Baker JM, et al. A case series of children with acute hepatitis and human adenovirus infection. N Engl J Med. 2022 2022 Aug 18;387(7):620–630. doi: 10.1056/NEJMoa2206294
   PubMed Web of Science ®Google Scholar
• Ho A, Orton R, Tayler R, et al. Nature. Adeno-associated virus 2 infection in children with non-A-E hepatitis. Online ahead of print;2023. doi: 10.1038/s41586-023-05948-2
   Google Scholar
• Morfopoulou S, Buddle S, Montaguth OET, et al. Genomic investigations of unexplained acute hepatitis in children. Nature. 2023 Mar 30;617(7961):564–573. Online ahead of print. doi:10.1038/s41586-023-06003-w
   PubMed Web of Science ®Google Scholar
• Servellita V, Gonzalez AS, Lamson DM, et al. Adeno-associated virus type 2 in US children with acute severe hepatitis. Nature. 2023;617(7961):574–580. doi: 10.1038/s41586-023-05949-1 Online ahead of print.
   PubMed Web of Science ®Google Scholar
• Samulski RJ, Muzyczka N. AAV-Mediated gene therapy for research and therapeutic purposes. Annu Rev Virol. 2014;1(1):427–451. doi: 10.1146/annurev-virology-031413-085355
   PubMedGoogle Scholar
• Kerr JR, Cotmore SF, Bloom R, editors et al. Parvoviruses. London. Hodder Arnold Publication; 2006. doi: 10.1201/b13393
   Google Scholar
• Muzyczka N, Berns K. Parvoviridae: the viruses and their replication. Fields Virology. 2001;2:2327–2359.
   Google Scholar
• Weitzman MD, Linden RM. Adeno-associated virus biology. Methods Mol Biol. 2011;807:1–23. doi: 10.1007/978-1-61779-370-7_1
   PubMedGoogle Scholar
• Moullier P, Snyder RO. International efforts for recombinant adeno-associated viral vector reference standards. Mol Ther. 2008;16(7):1185–1188. doi: 10.1038/mt.2008.125
   PubMed Web of Science ®Google Scholar
• Boutin S, Monteilhet V, Veron P, et al. Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors. Hum Gene Ther. 2010;21(6):704–712. doi: 10.1089/hum.2009.182
   PubMed Web of Science ®Google Scholar
• Calcedo R, Vandenberghe LH, Gao G, et al. Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses. J Infect Dis. 2009;199(3):381–390. doi: 10.1086/595830
   PubMed Web of Science ®Google Scholar
• Louis Jeune V, Joergensen JA, Hajjar RJ, et al. Pre-existing anti-adeno-associated virus antibodies as a challenge in AAV gene therapy. Hum Gene Ther Methods. 2013;24(2):59–67. doi: 10.1089/hgtb.2012.243
   PubMed Web of Science ®Google Scholar
• Chirmule N, Propert K, Magosin S, et al. Immune responses to adenovirus and adeno-associated virus in humans. Gene Ther. 1999;6(9):1574–1583. doi: 10.1038/sj.gt.3300994
   PubMed Web of Science ®Google Scholar
• Calcedo R, Morizono H, Wang L, et al. Adeno-associated virus antibody profiles in newborns, children, and adolescents. Clin Vaccine Immunol. 2011;18(9):1586–1588. doi: 10.1128/CVI.05107-11
   PubMed Web of Science ®Google Scholar
• Erles K, Sebökovà P, Schlehofer JR. Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV). J Med Virol. 1999;59(3):406–411. doi: 10.1002/(SICI)1096-9071(199911)59:3<406:AID-JMV22>3.0.CO;2-N
   PubMed Web of Science ®Google Scholar
• Gao G, Vandenberghe LH, Alvira MR, et al. Clades of adeno-associated viruses are widely disseminated in human tissues. J Virol. 2004;78(12):6381–6388. doi: 10.1128/JVI.78.12.6381-6388.2004
   PubMed Web of Science ®Google Scholar
• Grossman Z, Mendelson E, Brok-Simoni F, et al. Detection of adeno-associated virus type 2 in human peripheral blood cells. J Gen Virol. 1992;73(Pt 4):961–966. doi: 10.1099/0022-1317-73-4-961
   PubMedGoogle Scholar
• Sayyadi-Dehno Z, Seyed Khorrami SM, Ghavami N, et al. Molecular detection of adeno-associated virus DNA in cases of spontaneous and therapeutic abortion. Fetal Pediatr Pathol. 2019;38(3):206–214. doi: 10.1080/15513815.2019.1576817
   PubMed Web of Science ®Google Scholar
• Tobiasch E, Rabreau M, Geletneky K, et al. Detection of adeno-associated virus DNA in human genital tissue and in material from spontaneous abortion. J Med Virol. 1994;44(2):215–222. doi: 10.1002/jmv.1890440218
   PubMed Web of Science ®Google Scholar
• Walz CM, Anisi TR, Schlehofer JR, et al. Detection of infectious adeno-associated virus particles in human cervical biopsies. Virology. 1998;247(1):97–105. doi: 10.1006/viro.1998.9226
   PubMed Web of Science ®Google Scholar
• Hüser D, Khalid D, Lutter T, et al. High prevalence of infectious adeno-associated virus (AAV) in human peripheral blood mononuclear cells indicative of t lymphocytes as sites of AAV persistence. J Virol. 2017;91(4):e02137–16. doi: 10.1128/JVI.02137-16
   PubMed Web of Science ®Google Scholar
• Berns KI, Giraud C. Biology of adeno-associated virus. Curr Top Microbiol Immunol. 1996;218:1–23. doi: 10.1007/978-3-642-80207-2_1
   PubMed Web of Science ®Google Scholar
• Blacklow NR, Hoggan MD, Kapikian AZ, et al. Epidemiology of adenovirus-associated virus infection in a nursery population. Am J Epidemiol. 1968a;88(3):368–378. doi: 10.1093/oxfordjournals.aje.a120897
   PubMed Web of Science ®Google Scholar
• Blacklow NR, Hoggan MD, Rowe WP. Serologic evidence for human infection with adenovirus-associated viruses. J Natl Cancer Inst. 1968b;40(2):319–327.
   PubMed Web of Science ®Google Scholar
• Chand D, Mohr F, McMillan H, et al. Hepatotoxicity following administration of onasemnogene abeparvovec (AVXS-101) for the treatment of spinal muscular atrophy. J Hepatol. 2021;74(3):560–566. doi: 10.1016/j.jhep.2020.11.001
   PubMed Web of Science ®Google Scholar
• Chowdary P, Shapiro S, Makris M, et al. Phase 1-2 trial of AAVS3 gene therapy in patients with hemophilia B. N Engl J Med. 2022;387(3):237–247. doi: 10.1056/NEJMoa2119913
   PubMed Web of Science ®Google Scholar
• Mullard A. Gene therapy community grapples with toxicity issues, as pipeline matures. Nat Rev Drug Discov. 2021;20(11):804–805. doi: 10.1038/d41573-021-00164-x
   PubMed Web of Science ®Google Scholar
• Muzyczka N, Berns KI. AAV’s Golden Jubilee. Mol Ther. 2015;23(5):807–808. doi: 10.1038/mt.2015.55
   PubMed Web of Science ®Google Scholar
• Sant’anna TB, Araujo NM. Adeno-associated virus infection and its impact in human health: an overview. Virol J. 2022;19(1):173. doi: 10.1186/s12985-022-01900-4
   PubMed Web of Science ®Google Scholar
• La Bella T, Imbeaud S, Peneau C, et al. Adeno-associated virus in the liver: natural history and consequences in tumour development. Gut. 2020;69(4):737–747. doi: 10.1136/gutjnl-2019-318281
   PubMed Web of Science ®Google Scholar
• Nault JC, Datta S, Imbeaud S, et al. Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas.Nat Genet. 2015;47(10):1187–1193. doi: 10.1038/ng.3389
   Google Scholar
• Nault JC, Datta S, Imbeaud S, et al. Adeno-associated virus type 2 as an oncogenic virus in human hepatocellular carcinoma. Mol Cell Oncol. 2016;3(2):e1095271. doi: 10.1080/23723556.2015.1095271
   PubMedGoogle Scholar
• Tatsuno K, Midorikawa Y, Takayama T, et al. Impact of AAV2 and hepatitis B virus integration into genome on development of hepatocellular carcinoma in patients with prior hepatitis B virus infection. Clin Cancer Res. 2019;25(20):6217–6227. doi: 10.1158/1078-0432.CCR-18-4041
   PubMed Web of Science ®Google Scholar
• Berns KI, Byrne BJ, Flotte TR, et al. Adeno-Associated virus type 2 and hepatocellular carcinoma? Hum Gene Ther. 2015;26(12):779–781. doi: 10.1089/hum.2015.29014.kib
   PubMed Web of Science ®Google Scholar
• Büning H, Schmidt M. Adeno-associated vector toxicity-to be or not to be? Mol Ther. 2015;23(11):1673–1675. doi: 10.1038/mt.2015.182
   PubMed Web of Science ®Google Scholar
• Park KJ, Lee J, Park JH, et al. Adeno-associated virus 2-mediated hepatocellular carcinoma is very rare in Korean patients. Ann Lab Med. 2016;36(5):469–474. doi: 10.3343/alm.2016.36.5.469
   PubMed Web of Science ®Google Scholar
• Schäffer AA, Dominguez DA, Chapman LM, et al. Integration of adeno-associated virus (AAV) into the genomes of most Thai and Mongolian liver cancer patients does not induce oncogenesis. BMC Genomics. 2021;22(1):814. doi: 10.1186/s12864-021-08098-9
   PubMed Web of Science ®Google Scholar
• Kotin RM, Siniscalco M, Samulski RJ, et al. Site-specific integration by adeno-associated virus. Proc Natl Acad Sci, USA. 1990;87(6):2211–2215. doi: 10.1073/pnas.87.6.2211
   PubMed Web of Science ®Google Scholar
• Samulski RJ, Zhu X, Xiao X, et al. Targeted integration of adeno-associated virus (AAV) into human chromosome 19. Embo J. 1991;10(12):3941–3950. doi: 10.1002/j.1460-2075.1991.tb04964.x
   PubMed Web of Science ®Google Scholar
• Galibert L, Hyvönen A, Eriksson RAE, et al. Functional roles of the membrane associated AAV protein MAAP. Sci Rep. 2021;11(1):21698. doi: 10.1038/s41598-021-01220-7
   PubMed Web of Science ®Google Scholar
• Mietzsch M, Pénzes JJ, Agbandje-McKenna M. Twenty-five years of structural parvovirology. Viruses. 2019;11(4):362. doi: 10.3390/v11040362
   PubMed Web of Science ®Google Scholar
• Qiu J, Pintel DJ. The adeno-associated virus type 2 rep protein regulates RNA processing via interaction with the transcription template. Mol Cell Biol. 2002;22(11):3639–3652. doi: 10.1128/MCB.22.11.3639-3652.2002
   PubMed Web of Science ®Google Scholar
• Meyer NL, Chapman MS. Adeno-associated virus (AAV) cell entry: structural insights.Trends microbiol. 2022;30(5):432–451.doi: 10.1016/j.tim.2021.09.005
   Google Scholar
• Meyer NL, Hu G, Davulcu O, et al. Structure of the gene therapy vector, adeno-associated virus with its cell receptor. AAVR Elife. 2019;8:e44707. doi: 10.7554/eLife.44707
   PubMed Web of Science ®Google Scholar
• Zhang R, Cao L, Cui M, et al. Adeno-associated virus 2 bound to its cellular receptor AAVR. Nat Microbiol. 2019a;4(4):675–682. doi: 10.1038/s41564-018-0356-7
   PubMed Web of Science ®Google Scholar
• Zhang R, Xu G, Cao L, et al. Divergent engagements between adeno-associated viruses with their cellular receptor AAVR. Nat Commun. 2019b;10(1):3760. doi: 10.1038/s41467-019-11668-x
   PubMedGoogle Scholar
• Kambhampati AK, Burke RM, Dietz S, et al. Trends in acute hepatitis of unspecified etiology and adenovirus stool testing results in children - United States, 2017-2022. MMWR Morb Mortal Wkly Rep. 2022;71(24):797–802. doi: 10.15585/mmwr.mm7124e1
   PubMed Web of Science ®Google Scholar
• Leiskau C, Tsaka S, Meyer-Ruhnke L, et al. Acute severe non-A-E-hepatitis of unknown origin in children - a 30-year retrospective observational study from north-west Germany. Hepatol. 2023;78(5):971–978. doi: 10.1016/j.jhep.2022.12.012
   Google Scholar
• Martin NA, Gonzalez G, Reynolds LJ, et al. Adeno-associated virus 2 and human adenovirus F41 in wastewater during outbreak of severe acute hepatitis in children, Ireland. Emerg Infect Dis. 2023;29(4):751–760. doi: 10.3201/eid2904.221878
   PubMed Web of Science ®Google Scholar
• Reyne MI, Allen DM, Levickas A, et al. Detection of human adenovirus F41 in wastewater and its relationship to clinical cases of acute hepatitis of unknown aetiology. Sci Total Environ. 2023;857(Pt 2):159579. doi: 10.1016/j.scitotenv.2022.159579
   PubMedGoogle Scholar
• Messacar K, Baker RE, Park SW, et al. Preparing for uncertainty: endemic paediatric viral illnesses after COVID-19 pandemic disruption. Lancet. 2022;400(10364):1663–1665. doi: 10.1016/S0140-6736(22)01277-6
   PubMed Web of Science ®Google Scholar
• Al-Jwadi RF, Mills EHA, Torp-Pedersen C, et al. Consequences of COVID-19-related lockdowns and reopenings on emergency hospitalizations in pediatric patients in Denmark during 2020-2021. Eur J Pediatr. 2023;182(1):285–293. doi: 10.1007/s00431-022-04682-7
   PubMed Web of Science ®Google Scholar
• Amar S, Avni YS, O’Rourke N, et al. Prevalence of common infectious diseases after COVID-19 vaccination and easing of pandemic restrictions in Israel. JAMA Netw Open. 2022;5(2):e2146175. doi: 10.1001/jamanetworkopen.2021.46175
   PubMed Web of Science ®Google Scholar
• Benschop KS, Albert J, Anton A, et al. Re-emergence of enterovirus D68 in Europe after easing the COVID-19 lockdown, September 2021. Euro Surveill. 2021;26(45):2100998. doi: 10.2807/1560-7917.ES.2021.26.45.2100998
   PubMedGoogle Scholar
• Eden JS, Sikazwe C, Xie R, et al. Off-season RSV epidemics in Australia after easing of COVID-19 restrictions. Nat Commun; 13(1):2884. doi: 10.1038/s41467-022-30485-3
   PubMed Web of Science ®Google Scholar
• Korokhov N, Mikheeva G, Krendelshchikov A, et al. Targeting of adenovirus via genetic modification of the viral capsid combined with a protein bridge. J Virol. 2003;77(24):12931–12940. doi: 10.1128/jvi.77.24.12931-12940.2003
   PubMed Web of Science ®Google Scholar
• Krasnykh VN, Douglas JT, van Beusechem VW. Genetic targeting of adenoviral vectors. Mol Ther. 2000;1(5 Pt 1):391–405. doi: 10.1006/mthe.2000.0062
   PubMed Web of Science ®Google Scholar
• Krasnykh VN, Mikheeva GV, Douglas JT, et al. Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. J Virol. 1996;70(10):6839–6846. doi: 10.1128/JVI.70.10.6839-6846.1996
   PubMed Web of Science ®Google Scholar
• Noureddini SC, Curiel DT. Genetic targeting strategies for adenovirus. Mol Pharm. 2005;2(5):341–347. doi: 10.1021/mp050045c
   PubMed Web of Science ®Google Scholar
• Wickham TJ, Tzeng E, Shears LL 2nd, et al. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. J Virol. 1997;71(11):8221–8229. doi: 10.1128/JVI.71.11.8221-8229.1997
   PubMed Web of Science ®Google Scholar
• Nakamura T, Sato K, Hamada H. Reduction of natural adenovirus tropism to the liver by both ablation of fiber-coxsackievirus and adenovirus receptor interaction and use of replaceable short fiber. J Virol. 2003;77(4):2512–2521. doi: 10.1128/jvi.77.4.2512-2521.2003
   PubMed Web of Science ®Google Scholar
• Hsu HL, Brown A, Loveland AB, et al. Structural characterization of a novel human adeno-associated virus capsid with neurotropic properties. Nat Commun. 2020;11(1):3279. doi: 10.1038/s41467-020-17047-1
   PubMed Web of Science ®Google Scholar
• Brisca G, Mallamaci M, Tardini G, et al. Brisca-CoV-2 infection may present as acute hepatitis in children. Pediatr Infect Dis J. 2021;40(5):e214–e215. doi: 10.1097/INF.0000000000003098
   PubMed Web of Science ®Google Scholar
• Mameli S, Marcialis MA, Bassareo PP, et al. COVID-19 and hepatic damage: what we know? Panminerva Med. 2023;65(1):58–64. doi: 10.23736/S0031-0808.21.04239-7
   PubMed Web of Science ®Google Scholar
• Sun J, Aghemo A, Forner A, et al. COVID-19 and liver disease. Liver Int. 2020;40:1278–1281. doi: 10.1111/liv.14470
   PubMedGoogle Scholar
• Wander P, Epstein M, Bernstein D. COVID-19 presenting as acute hepatitis. Am J Gastroenterol. 2020;115(6):941–942. doi: 10.14309/ajg.0000000000000660
   PubMed Web of Science ®Google Scholar